Scarica l'app Stockscreener
36.85
0.03%
0.010
Dopo l'orario di chiusura:
36.85
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$36.84
Aprire:
$36.92
Volume 24 ore:
2.01M
Relative Volume:
0.54
Capitalizzazione di mercato:
$15.93B
Reddito:
$2.31B
Utile/perdita netta:
$1.66B
Rapporto P/E:
16.04
EPS:
2.297
Flusso di cassa netto:
$827.02M
1 W Prestazione:
+1.40%
1M Prestazione:
+1.68%
6M Prestazione:
+16.28%
1 anno Prestazione:
+34.69%
Intervallo 1D:
$36.69
$37.16
Intervallo di 1 settimana:
$36.11
$37.69
Portata 52W:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
36.85 | 16.20B | 2.31B | 1.66B | 827.02M | 2.297 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.63 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.00 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.69 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.18 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.03 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Goldman | Buy |
| 2025-05-16 | Iniziato | Morgan Stanley | Overweight |
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Can Royalty Pharma plc stock beat analyst upgradesAnalyst Upgrade & Weekly High Return Forecasts - newser.com
Is Royalty Pharma plc reversing from oversold territoryWatch List & Safe Entry Point Identification - newser.com
Does Royalty Pharma plc qualify in momentum factor screeningEarnings Overview Summary & Advanced Technical Signal Analysis - newser.com
Cullen Frost Bankers Inc. Increases Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Purchased by Cookson Peirce & Co. Inc. - MarketBeat
What’s the recovery path for long term holders of Royalty Pharma plcEarnings Trend Report & Low Risk Entry Point Tips - newser.com
Detecting support and resistance levels for Royalty Pharma plcMarket Performance Report & Daily Entry Point Alerts - newser.com
What indicators show strength in Royalty Pharma plcShort Setup & Real-Time Volume Analysis Alerts - newser.com
Allspring Global Investments Holdings LLC Has $881,000 Stake in Royalty Pharma PLC $RPRX - MarketBeat
Using Python tools to backtest Royalty Pharma plc strategies2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com
Why retail investors pile into Royalty Pharma plc stockEarnings Recap Report & Smart Money Movement Tracker - newser.com
What analysts say about Royalty Pharma plc RPD stockDividend Stability Analysis & Free Transform Portfolio With Stocks - earlytimes.in
Why Royalty Pharma plc (RPD) stock could outperform next yearMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com
What the charts say about Royalty Pharma plc todayJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com
What analysts say about Royalty Pharma plc stockEmerging Market Stocks & Subscribe for Free Weekly Winners - earlytimes.in
Royalty Pharma PLC $RPRX Shares Bought by TD Asset Management Inc - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Short Interest Update - MarketBeat
Allianz Asset Management GmbH Increases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc (RPD) stock a buy during volatile markets2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Is Royalty Pharma plc (RPD) stock undervalued historicallyWeekly Trading Summary & Verified Technical Trade Signals - nchmf.gov.vn
Is this a good reentry point in Royalty Pharma plcWeekly Stock Recap & Stepwise Trade Signal Guides - newser.com
What candlestick patterns are forming on Royalty Pharma plcWeekly Gains Report & Smart Money Movement Tracker - newser.com
Price-Driven Insight from (RPRX) for Rule-Based Strategy - news.stocktradersdaily.com
Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 20% Potential Upside in the Biotech Royalty Landscape - DirectorsTalk Interviews
Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics - sharewise.com
Nordea Investment Management AB Boosts Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) to Issue Quarterly Dividend of $0.22 - MarketBeat
Is Royalty Pharma plc (RPD) stock bottoming after sell offEarnings Risk Summary & Stepwise Swing Trade Plans - nchmf.gov.vn
How strong is Royalty Pharma plc stock revenue growth2025 Key Lessons & Proven Capital Preservation Tips - nchmf.gov.vn
Market Moves: How strong is Royalty Pharma plc stock revenue growthTake Profit & Precise Buy Zone Identification - nchmf.gov.vn
Will Royalty Pharma plc stock benefit from upcoming earnings reports2025 EndofYear Setup & Consistent Return Strategy Ideas - nchmf.gov.vn
Trading Recap: Is Royalty Pharma plc (RPD) stock positioned for secular growth2025 Technical Overview & Fast Exit and Entry Strategy Plans - nchmf.gov.vn
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.42%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):